top of page

KIDNEY  TRANSPLANTATION  STUDIES

MERCURY
STUDY HOME

OPEN ENROLLMENT

Novel desensitization protocol for highly sensitized patients to allow for successful kidney transplantation.
A pilot study. (IRB21-0323-CR001)

COMPLETED

A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis (FSGS) in de novo Kidney Transplant Recipients.

​

Funded by Astellas Pharma Global Development, Inc.

COMPLETED

Read more

Mercury- Living Donor Kidney Tx (with Bone Marrow) 

A Phase 3 Prospective, Randomized, Multi-center, Open-label, Controlled Trial to Assess the Efficacy and Safety of Cellular Immunotherapy with MDR-101 for Induction of Immune Tolerance in Recipients of HLA-matched, Living Donor Kidney Transplants

​

Funded by Medeor Therapeutics, Inc

COMPLETED

A randomized double-blind placebo-controlled study to evaluate the efficacy and safety of CINRYZE® (C1 esterase inhibitor [human]) for the treatment of acute antibody-mediated rejection in kidney transplant patients. 

​

Funded by Shire ViroPharma, Inc.. 

COMPLETED

A Phase 2a, Randomized, Open-Label, Active Control, Multi- Center Study to Assess the Efficacy and Safety of ASKP1240 in de novo Kidney Transplant Recipients

​

Funded by Astellas Pharma Global Development, Inc.

COMPLETED

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ from a CMV-Seropositive Donor.

 

Funded by Astellas Pharma Global Development, Inc. 

bottom of page